Publication|Articles|December 12, 2025
Supplements and Featured Publications
- 2025 Year in Review: Clostridioides difficile Infection
2025 Year in Review: Clostridioides difficile Infection
This year in review of 2025 milestones in Clostridioides difficile infection features coverage of research on infection patterns presented at the American Society for Microbiology Microbe 2025 meeting in June and comparative studies of treatment efficacy and prevention strategies. It also includes an interview with Paul Feuerstadt, MD, on recent developments in C difficile diagnosis and treatment.
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
5 Key Oncology FDA Approvals From November
5






































